Mood Disorders Are Significantly More Common in ASD
And Challenging to Diagnose Due to Atypical Presentation A recent British review article published in the International Review of Psychiatry presented a thorough investigation into the occurrence of higher rates of mood disorders in individuals with autism than in the general population. The most common mood disorders include major depressive disorder, bipolar disorder and seasonal […]
Community Shares | March 2nd
Community Shares A new study shows that early puberty is common in girls on the spectrum and calls for better preparation to make the transition for these young ladies go more smoothly. The New Jersey Autism Center for Excellence (NJACE) has released a new webinar on the Developmental, Individual Difference, Relationship-based Model (DIR) therapy which […]
Survey of Mental Health, Substance Abuse, and Suicidal Ideation for American Adults During Early Phases of the COVID-19 Pandemic
Higher Rates of Distress Exhibited by Individuals with Disabilities, Caregivers, and People with Sleep Problems New research published in the Journal of American Medical Association (JAMA) focuses on a survey that examined mental health symptoms of American adults during the early phase (April-June 2020) of the coronavirus pandemic. The results of this survey are not […]
How Gut Microbes and Brain Disorders Could Be Linked
Findings May Lead to Microbiome Drugs for Neurodegenerative and Neuropsychiatric Disorders Fifteen years ago, neuroscientist Jane Foster discovered that bacteria in the gut may have influence over brain function and behavior. She came to this conclusion by conducting studies using two groups of mice. One group had healthy gut microbes and the other group lacked […]
Further Details Show Psilocybin to be a Budding New Autism Treatment
The Psychedelic Substance Supports Microbiome and Normalizes Serotonin Levels Last month, SafeMinds Shares reported on the stir psilocybin was creating in the financial world. Market analysts and investors were viewing the psychedelic as a potential revolutionary autism treatment. The autism treatment market is currently valued at $3.2 billion and is desperately lacking in drug therapies. […]
IACC Continues to Disappoint the Autism Community
Committee Has Not Met Since 2019, Each Panel Member’s Terms Has Expired The Interagency Autism Coordinating Committee (IACC) is the organization that oversees the nation’s efforts to manage the autism epidemic. Authorized by congress, the IACC is responsible for providing autism policy advice to the secretary of health and human services (HHS). Shockingly, this committee […]
